These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

32 related articles for article (PubMed ID: 29562855)

  • 1. Effect of dendritic cell-cytokine-induced killer cells in patients with advanced colorectal cancer combined with first-line treatment.
    Xie Y; Huang L; Chen L; Lin X; Chen L; Zheng Q
    World J Surg Oncol; 2017 Nov; 15(1):209. PubMed ID: 29179719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced antitumor effects of DC-activated CIKs to chemotherapy treatment in a single cohort of advanced non-small-cell lung cancer patients.
    Yang L; Ren B; Li H; Yu J; Cao S; Hao X; Ren X
    Cancer Immunol Immunother; 2013 Jan; 62(1):65-73. PubMed ID: 22744010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autologous cytokine-induced killer cell immunotherapy in lung cancer: a phase II clinical study.
    Li R; Wang C; Liu L; Du C; Cao S; Yu J; Wang SE; Hao X; Ren X; Li H
    Cancer Immunol Immunother; 2012 Nov; 61(11):2125-33. PubMed ID: 22581306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective effect of cytokine-induced killer cells on survival of patients with early-stage melanoma.
    Li H; Huang L; Liu L; Wang X; Zhang Z; Yue D; He W; Fu K; Guo X; Huang J; Zhao X; Zhu Y; Wang L; Dong W; Yan Y; Xu L; Gao M; Yang S; Zhang Y
    Cancer Immunol Immunother; 2017 Mar; 66(3):299-308. PubMed ID: 27889798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adoptive immunotherapy of cytokine-induced killer cell therapy in the treatment of non-small cell lung cancer.
    Wang M; Cao JX; Pan JH; Liu YS; Xu BL; Li D; Zhang XY; Li JL; Liu JL; Wang HB; Wang ZX
    PLoS One; 2014; 9(11):e112662. PubMed ID: 25412106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of postoperative adjuvant transfusion of cytokine-induced killer cells combined with chemotherapy in patients with colorectal cancer.
    Zhu Y; Zhang H; Li Y; Bai J; Liu L; Liu Y; Qu Y; Qu X
    Cancer Immunol Immunother; 2013 Oct; 62(10):1629-35. PubMed ID: 23974720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II clinical trial of ex vivo-expanded cytokine-induced killer cells therapy in advanced pancreatic cancer.
    Chung MJ; Park JY; Bang S; Park SW; Song SY
    Cancer Immunol Immunother; 2014 Sep; 63(9):939-46. PubMed ID: 24916038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokine-Induced Killer Cells Express CD39, CD38, CD203a, CD73 Ectoenzymes and P1 Adenosinergic Receptors.
    Horenstein AL; Chillemi A; Zini R; Quarona V; Bianchi N; Manfredini R; Gambari R; Malavasi F; Ferrari D
    Front Pharmacol; 2018; 9():196. PubMed ID: 29731713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Learning from CIK plants.
    Xu F; Jackson D
    Nat Plants; 2018 Apr; 4(4):195-196. PubMed ID: 29581512
    [No Abstract]   [Full Text] [Related]  

  • 10. Cytokine-induced killer (CIK) cells, successes and challenges: report on the first international conference dedicated to the clinical translation of this unique adoptive cell immunotherapy.
    Sharma A; Ren X; Rosato A; Sangiolo D; Wang Z; Tettamanti S; Zhang Y; Rettinger E; Fenix KA; Sommaggio R; Cappuzzello E; Schmidt-Wolf IGH
    Cancer Immunol Immunother; 2024 Jan; 73(2):21. PubMed ID: 38279995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination of PD-1 blockade and RetroNectin
    Zhao L; Han L; Zhang Y; Li T; Yang Y; Li W; Shang Y; Lin H; Gao Q
    Immunotherapy; 2018 Nov; 10(15):1315-1323. PubMed ID: 30350739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of dendritic cells co-cultured with cytokine-induced killer cells immunotherapy for non-small-cell lung cancer.
    Wang S; Wang Z
    Int Immunopharmacol; 2015 Sep; 28(1):22-8. PubMed ID: 26013109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytokine-induced killer cells in the treatment of patients with renal cell carcinoma: a pooled meta-analysis.
    Wang ZX; Li JL; Cao JX; Liu YS; Li D; Zhang XY; Wang M; Wu M; Xu BL; Liu JL; Wang HB
    Immunotherapy; 2014; 6(6):787-95. PubMed ID: 25186607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival benefit from RectroNectin-activated cytokine-induced killer cells combined with chemotherapy in advanced EGFR wild-type lung adenocarcinoma.
    Zhao L; Li W; Wang Z; Yang Y; Zhang Y; Shang Y; Ren X; Gao Q
    Immunotherapy; 2018 Mar; 10(6):501-510. PubMed ID: 29562855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of the number and interval of treatment cycles on cytokine-induced killer cells and their adjuvant therapeutic effects in advanced non-small-cell lung cancer (NSCLC).
    Gu Y; Lv H; Zhao J; Li Q; Mu G; Li J; Wuyang J; Lou G; Wang R; Zhang Y; Huang X
    Int Immunopharmacol; 2017 Sep; 50():263-269. PubMed ID: 28711032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autologous cytokine-induced killer cell therapy in lung cancer patients: a retrospective study.
    Zhang J; Zhu L; Du H; He X; Yin Y; Gu Y; Liu L; Lu K; Guo R; Liu P; Shu Y
    Biomed Pharmacother; 2015 Mar; 70():248-52. PubMed ID: 25776508
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.